Robert F. Gruener

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.

Fan Wang, Aritro Nath, Robert L Grossman, 2017, Genome research.

More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens.

R. S. Huang, Robert F. Gruener, Robert F Gruener, 2018, Pharmacology & therapeutics.

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies

R. Grossman, R. S. Huang, Paul Geeleher, 2017, Genome research.

oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data

Robert F. Gruener, D. Maeser, R. Huang, 2021, Briefings Bioinform..

IMMU-03. CHARACTERIZING THE IMMUNE MICROENVIRONMENT OF PEDIATRIC BRAIN TUMORS

R. S. Huang, Robert F. Gruener, R. Galvin, 2021, Neuro-Oncology.

Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling

R. S. Huang, G. Greene, Robert F. Gruener, 2021, Cancers.

Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars

F. Furnari, D. Kawauchi, A. Mackay, 2023, bioRxiv.

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis

Robert F. Gruener, D. Maeser, Weijie Zhang, 2024, Pharmaceuticals.